BerGenBio ASA's market cap is currently $4.32M. The company's EPS TTM is $-0.13763299; its P/E ratio is ―; BerGenBio ASA is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
